ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 134 filers reported holding ACLARIS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,425 | -33.9% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $5,185 | +28.2% | 500 | 0.0% | 0.00% | – |
| Q1 2023 | $4,045 | -48.6% | 500 | 0.0% | 0.00% | – |
| Q4 2022 | $7,875 | -1.6% | 500 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | +14.3% | 500 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 500 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +28.6% | 500 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -22.2% | 500 | 0.0% | 0.00% | – |
| Q3 2021 | $9,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -30.8% | 500 | 0.0% | 0.00% | – |
| Q1 2021 | $13,000 | +333.3% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $3,000 | +200.0% | 500 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endurant Capital Management LP | 1,769,785 | $1,911,000 | 0.69% |
| Telemetry Investments, L.L.C. | 214,593 | $232,000 | 0.67% |
| Aisling Capital Management LP | 634,455 | $685,000 | 0.36% |
| Broadfin Capital, LLC | 1,620,000 | $1,750,000 | 0.32% |
| MFN Partners Management, LP | 1,500,000 | $1,620,000 | 0.24% |
| Sofinnova Investments, Inc. | 1,911,573 | $2,064,000 | 0.19% |
| Rock Springs Capital Management LP | 2,974,754 | $3,213,000 | 0.13% |
| Alambic Investment Management, L.P. | 150,636 | $163,000 | 0.12% |
| Cormorant Asset Management, LP | 250,000 | $270,000 | 0.02% |
| Man Group plc | 3,734,793 | $4,034,000 | 0.02% |